Correction (DOI:10.1016/j.jcin.2009.05.002);The Relative Renal Safety of Iodixanol Compared With Low-Osmolar Contrast Media. A Meta-Analysis of Randomized Controlled Trials

JACC: Cardiovascular Interventions

Volumn 2, Issue 7, 2009, Pages 645-654

  Reed, Michael ^a   Meier, Pascal ^a   Tamhane, Umesh U ^a   Welch, Kathy B ^b   Moscucci, Mauro ^c   Gurm, Hitinder S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

contrast media; contrast induced acute kidney injury; contrast induced nephropathy; iodixanol; low osmolar contrast media; meta analysis

Indexed keywords

CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; IOVERSOL; IOXAGLIC ACID; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE;

ARTICLE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; DEATH; DRUG SAFETY; HEMODIALYSIS; HUMAN; INCIDENCE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; CONSUMER PRODUCT SAFETY; CONTRAST MEDIA; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; IOHEXOL; IOPAMIDOL; IOXAGLIC ACID; KIDNEY DISEASES; MALE; MIDDLE AGED; ODDS RATIO; OSMOLAR CONCENTRATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TRIIODOBENZOIC ACIDS;

EID: 67650709416     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.09.003     Document Type: Erratum

References (44)

1. Rich M.W., and Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150 (1990) 1237-1242
2. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
3. Gurm H.S., Lincoff A.M., Kleiman N.S., et al. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004) 30-34
4. Gupta R., Gurm H.S., Bhatt D.L., Chew D.P., and Ellis S.G. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64 (2005) 442-448
5. Liss P., Persson P.B., Hansell P., and Lagerqvist B. Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 70 (2006) 1811-1817
6. Nallamothu B.K., Shojania K.G., Saint S., et al. Is acetylcysteine effective in preventing contrast-related nephropathy?. A meta-analysis. Am J Med 117 (2004) 938-947
7. Hogan S.E., L'Allier P., Chetcuti S., et al. Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 156 (2008) 414-421
8. Briguori C., Airoldi F., D'Andrea D., et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115 (2007) 1211-1217
9. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
10. Rosovsky M.A., Rusinek H., Berenstein A., Basak S., Setton A., and Nelson P.K. High-dose administration of nonionic contrast media: a retrospective review. Radiology 200 (1996) 119-122
11. Kahn J.K., Rutherford B.D., McConahay D.R., et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J 120 (1990) 533-536
12. Barrett B.J., and Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
13. Barrett B.J., Parfrey P.S., Vavasour H.M., et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 41 (1992) 1274-1279
14. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
15. Jo S.H., Youn T.J., Koo B.K., et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 924-930
16. McCullough P.A., Bertrand M.E., Brinker J.A., and Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48 (2006) 692-699
17. Detrenis S., Meschi M., and Savazzi G. Contrast nephropathy: isosmolar and low-osmolar contrast media. J Am Coll Cardiol 49 (2007) 922-923
18. Anderson J.L., Adams C.D., Antman E.M., et al., American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction), American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) e1-e157
19. Kuhn M.J., Chen N., Sahani D.V., et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or iso-osmolar contrast agent exposure. AJR Am J Roentgenol 191 (2008) 151-157
20. Thomsen H.S., Morcos S.K., Erley C.M., et al., Investigators in the Abdominal Computed Tomography: IOMERON 400 Versus VISIPAQUE 320 Enhancement (ACTIVE) Study. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 43 (2008) 170-178
21. Rudnick M.R., Davidson C., Laskey W., Stafford J.L., Sherwin P.F., and VALOR Trial Investigators. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am Heart J 156 (2008) 776-782
22. Solomon R.J., Natarajan M.K., Doucet S., et al., CARE Study Investigators. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115 (2007) 3189-3196
23. Heinrich M.C., Haberle L., Muller V., Bautz W., and Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 250 (2009) 68-86
24. Juni P., Witschi A., Bloch R., and Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282 (1999) 1054-1060
25. Sankey S., Weissfeld L., Fine M., et al. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat Simul Comput 25 (1996) 1031-1056
26. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
27. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
28. Orwin R. A fail-safe test for effect size in meta-analysis. J Educ Stat 8 (1983) 157-159
29. Rosenberg M.S. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Evol Int J Org Evol 59 (2005) 464-468
30. Duval S., and Tweedie R. A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000) 455-463
31. West B., Welch K., and Galecki A. Linear Mixed Models: A Practical Guide Using Statistical Software (2006), Chapman and Hall/CRC Press, Boca Raton, FL
32. Andersen P.E., Bolstad B., Berg K.J., Justesen P., Thayssen P., and Kloster Y.F. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Clin Radiol 48 (1993) 268-272
33. Aspelin P. Reduced risk of nepropathy with iso-osmolar contrast media. Lakartidningen 100 (2003) 2067-2068
34. Barrett B.J., Katzberg R.W., Thomsen H.S., et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41 (2006) 815-821
35. Carraro M., Malalan F., Antonione R., et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol 8 (1998) 144-147
36. Chalmers N., and Jackson R.W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72 (1999) 701-703
37. Feldkamp T., Baumgart D., Elsner M., et al. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. Clin Nephrol 66 (2006) 322-330
38. Juergens K.U., Oei M.L., Weckesser M., et al. Whole-body imaging of oncologic patients using 16-channel PET-CT. Evaluation of an i.v. contrast enhanced MDCT protocol. Nuklearmedizin 47 (2008) 30-36
39. Klow N.E., Levorstad K., Berg K.J., et al. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol 34 (1993) 72-77
40. Mehran R. Ionic Versus Non-Ionic Contrast To Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients ICON. Presentation at Transcatheter Cardiovascular Therapeutics (TCT) Conference (2006)
41. Nguyen S.A., Suranyi P., Ravenel J.G., et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 248 (2008) 97-105
42. Tveit K., Bolz K.D., Bolstad B., et al. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol 35 (1994) 614-618
43. Persson P.B., Hansell P., and Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68 (2005) 14-22
44. Klause N., Arendt T., Lins M., and Gronow G. Hypoxic renal tissue damage by endothelin-mediated arterial vasoconstriction during radioangiography in man. Adv Exp Med Biol 454 (1998) 225-234